誉衡药业

002437 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

7.1B ($1.0B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

2.4B

Net Income

243.0M

Gross Margin

N/A

Op. Margin

11.7%

Net Margin

10.0%

ROE

12.3%

ROA

8.6%

D/E

0.43

Dividend Yield

N/A

EPS

0.10

Current Ratio

1.07

Price History

Company Info

Industry	C27医药制造业
Market Segment	SME
Currency	CNY
Fiscal Year	2024

Business Overview

HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People's Republic of China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 誉衡药业

Ticker	002437
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业